Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Echinococcus multilocularis | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Schistosoma mansoni | microtubule-associated protein tau | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Schistosoma japonicum | ko:K04380 microtubule-associated protein tau, putative | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 | |
Echinococcus granulosus | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.1421 | 1 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.1348 | 0.9457 | 0.9457 |
Entamoeba histolytica | cdc48-like protein, putative | 0.1348 | 0.9457 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.1421 | 1 | 1 |
Mycobacterium tuberculosis | Putative conserved ATPase | 0.0851 | 0.5767 | 0.5 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.1348 | 0.9457 | 1 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.1348 | 0.9457 | 1 |
Toxoplasma gondii | transitional endoplasmic reticulum ATPase, putative | 0.0851 | 0.5767 | 0.5767 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0588 | 0.3817 | 0.3817 |
Toxoplasma gondii | cell division protein CDC48CY | 0.1421 | 1 | 1 |
Trypanosoma brucei | Valosin-containing protein | 0.1348 | 0.9457 | 1 |
Brugia malayi | valosin containing protein | 0.0833 | 0.564 | 1 |
Brugia malayi | vesicle-fusing ATPase | 0.0833 | 0.564 | 1 |
Onchocerca volvulus | Transitional endoplasmic reticulum ATPase homolog | 0.1421 | 1 | 1 |
Trichomonas vaginalis | 26S protease regulatory subunit S10b, putative | 0.0336 | 0.195 | 0.195 |
Loa Loa (eye worm) | hypothetical protein | 0.0833 | 0.564 | 1 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.1421 | 1 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.5639 | 0.5639 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.5639 | 0.5639 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0588 | 0.3817 | 0.3817 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.5639 | 0.5639 |
Trichomonas vaginalis | proteasome-activating nucleotidase, putative | 0.0336 | 0.195 | 0.195 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.1348 | 0.9457 | 1 |
Brugia malayi | transitional endoplasmic reticulum ATPase TER94, putative | 0.0588 | 0.3817 | 0.6768 |
Mycobacterium ulcerans | ATPase | 0.0851 | 0.5767 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.1579 | 0.1579 |
Giardia lamblia | AAA family ATPase | 0.0851 | 0.5767 | 1 |
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.1348 | 0.9457 | 1 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0833 | 0.564 | 1 |
Loa Loa (eye worm) | VCP protein | 0.0588 | 0.3817 | 0.6768 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0851 | 0.5767 | 0.5767 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.1322 | 0.2343 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.1348 | 0.9457 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.1322 | 0.2343 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.